MX9603092A - Nuevos compuestos con efecto analgesico y anestesico local. - Google Patents

Nuevos compuestos con efecto analgesico y anestesico local.

Info

Publication number
MX9603092A
MX9603092A MX9603092A MX9603092A MX9603092A MX 9603092 A MX9603092 A MX 9603092A MX 9603092 A MX9603092 A MX 9603092A MX 9603092 A MX9603092 A MX 9603092A MX 9603092 A MX9603092 A MX 9603092A
Authority
MX
Mexico
Prior art keywords
new compounds
analgesic
local anaesthetic
anaesthetic effect
effect
Prior art date
Application number
MX9603092A
Other languages
English (en)
Inventor
Anna-Lena Ask
Lars-Inge Olsson
Rune Sandberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9603092A publication Critical patent/MX9603092A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen los nuevos compuestos de la formula (A), un proceso para su preparacion y su uso en la fabricacion de preparaciones farmacéuticas. Los nuevos compuestos tiene ambos, efecto anestésico local y analgésico.
MX9603092A 1994-02-11 1995-02-03 Nuevos compuestos con efecto analgesico y anestesico local. MX9603092A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400447A SE9400447D0 (sv) 1994-02-11 1994-02-11 New compounds
PCT/SE1995/000106 WO1995021821A1 (en) 1994-02-11 1995-02-03 New compounds with analgesic and local anaesthetic effect

Publications (1)

Publication Number Publication Date
MX9603092A true MX9603092A (es) 1997-03-29

Family

ID=20392881

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603092A MX9603092A (es) 1994-02-11 1995-02-03 Nuevos compuestos con efecto analgesico y anestesico local.

Country Status (31)

Country Link
US (2) US5756520A (es)
EP (1) EP0743940B1 (es)
JP (1) JPH09508904A (es)
CN (1) CN1067989C (es)
AT (1) ATE192435T1 (es)
AU (1) AU686760B2 (es)
BR (1) BR9506748A (es)
CA (1) CA2181068A1 (es)
CZ (1) CZ286753B6 (es)
DE (1) DE69516671T2 (es)
DK (1) DK0743940T3 (es)
EE (1) EE03252B1 (es)
ES (1) ES2148493T3 (es)
FI (1) FI963128A (es)
GR (1) GR3033999T3 (es)
HR (1) HRP950414B1 (es)
HU (1) HU216734B (es)
IL (1) IL112374A (es)
IS (1) IS1771B (es)
MX (1) MX9603092A (es)
MY (1) MY130166A (es)
NO (1) NO306718B1 (es)
NZ (1) NZ281355A (es)
PL (1) PL180212B1 (es)
PT (1) PT743940E (es)
RU (1) RU2145599C1 (es)
SE (1) SE9400447D0 (es)
SK (1) SK281931B6 (es)
TW (1) TW348176B (es)
WO (1) WO1995021821A1 (es)
ZA (1) ZA95709B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523526D0 (en) * 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
DE19912889A1 (de) * 1999-03-23 2000-09-28 Daimler Chrysler Ag Verfahren zur Herstellung eines Ventilsitzes
WO2004054974A2 (en) * 2002-12-13 2004-07-01 Smithkline Beecham Corporation Piperidine derivatives as ccr5 antagonists
CL2007002958A1 (es) * 2006-10-12 2008-05-09 Epix Delaware Inc Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
AU2008335135A1 (en) 2007-12-11 2009-06-18 Cytopathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
US8473062B2 (en) * 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) * 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
WO2020152212A1 (en) 2019-01-22 2020-07-30 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951080A (en) * 1957-08-05 1960-08-30 Lilly Co Eli Novel phenyl-substituted piperidines
NL130088C (es) * 1960-03-14
US3850935A (en) * 1971-10-16 1974-11-26 Sumitomo Chemical Co Process for producing piperidine derivatives by degrading quaternary piperidinium salts
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
US5661162A (en) * 1992-12-14 1997-08-26 Merck Sharp & Dohme Limited 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists

Also Published As

Publication number Publication date
NZ281355A (en) 1998-02-26
JPH09508904A (ja) 1997-09-09
IS4251A (is) 1995-08-12
CZ203296A3 (en) 1996-12-11
CA2181068A1 (en) 1995-08-17
PL180212B1 (pl) 2001-01-31
US5756520A (en) 1998-05-26
HU216734B (hu) 1999-08-30
ATE192435T1 (de) 2000-05-15
PL315777A1 (en) 1996-12-09
FI963128A0 (fi) 1996-08-09
NO963292L (no) 1996-08-07
RU2145599C1 (ru) 2000-02-20
HRP950414B1 (en) 2001-02-28
HUT75641A (en) 1997-05-28
NO963292D0 (no) 1996-08-07
WO1995021821A1 (en) 1995-08-17
DE69516671D1 (de) 2000-06-08
IL112374A (en) 1999-12-31
CN1140448A (zh) 1997-01-15
HU9602206D0 (en) 1996-10-28
ES2148493T3 (es) 2000-10-16
EE03252B1 (et) 2000-02-15
TW348176B (en) 1998-12-21
DK0743940T3 (da) 2000-08-14
ZA95709B (en) 1995-08-11
HRP950414A2 (en) 1997-10-31
EP0743940B1 (en) 2000-05-03
IL112374A0 (en) 1995-03-30
BR9506748A (pt) 1997-09-16
US5968953A (en) 1999-10-19
NO306718B1 (no) 1999-12-13
FI963128A (fi) 1996-08-09
CZ286753B6 (en) 2000-06-14
CN1067989C (zh) 2001-07-04
PT743940E (pt) 2000-08-31
DE69516671T2 (de) 2001-02-01
AU1826995A (en) 1995-08-29
IS1771B (is) 2001-05-28
AU686760B2 (en) 1998-02-12
SE9400447D0 (sv) 1994-02-11
GR3033999T3 (en) 2000-11-30
SK281931B6 (sk) 2001-09-11
EP0743940A1 (en) 1996-11-27
MY130166A (en) 2007-06-29
SK92896A3 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
ZA953701B (en) New atagonist compounds
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MY119403A (en) Novel compounds with analgesic effect.
MX9603092A (es) Nuevos compuestos con efecto analgesico y anestesico local.
HK22997A (en) Substituted 4-phenyl-4-piperidine-carboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
CZ20022240A3 (cs) Mannichovy báze substituovaného 1-a 2-naftolu
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
JO1658B1 (en) New vehicles
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.
CA2189140A1 (en) New antagonist compounds
IT1269735B (it) Prodotti provvisti di un gruppo nitroestere terminale dotati di attivita' anti-infiammatoria e/o analgesica